Gainers

• OneMedNet (NASDAQ:ONMD) stock moved upwards by 78.5% to $1.26 during Friday's regular session. The company's market cap stands at $35.9 million.
• Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 62.0% to $0.64. The company's market cap stands at $1.3 million.
• Edesa Biotech (NASDAQ:EDSA) shares increased by 43.88% to $2.23. The company's market cap stands at $12.9 million.
• Neurogene (NASDAQ:NGNE) stock rose 33.13% to $26.2. The market value of their outstanding shares is at $304.8 million.
• Klotho Neurosciences (NASDAQ:KLTO) stock rose 22.82% to $0.59. The company's market cap stands at $34.6 million.
• Relay Therapeutics (NASDAQ:RLAY) shares moved upwards by 19.85% to $10.98. The market value of their outstanding shares is at $1.5 billion. The company's, Q4 earnings came out yesterday.

Losers

• Fulgent Genetics (NASDAQ:FLGT) shares decreased by 36.1% to $15.81 during Friday's regular session. The company's market cap stands at $765.3 million. As per the press release, Q4 earnings came out today.
• Modular Medical (NASDAQ:MODD) stock declined by 27.87% to $0.32. The company's market cap stands at $34.1 million.
• Ginkgo Bioworks Holdings (NYSE:DNA) shares fell 24.72% to $7.31. The market value of their outstanding shares is at $588.3 million. The company's, Q4 earnings came out yesterday.
• Emergent BioSolutions (NYSE:EBS) stock declined by 22.84% to $8.56. The company's market cap stands at $582.9 million. The company's, Q4 earnings came out yesterday.
• Progyny (NASDAQ:PGNY) shares declined by 22.48% to $17.25. The market value of their outstanding shares is at $1.9 billion. As per the news, the Q4 earnings report came out yesterday.
• Puma Biotechnology (NASDAQ:PBYI) shares fell 21.45% to $5.97. The company's market cap stands at $382.9 million. As per the press release, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.